Mariia O. Yuneva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mariia O. Yuneva has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chunmei Wang
Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America
1 shared publication - Dana Ferraris
McDaniel College Department of Chemistry, Westminster, USA
1 shared publication Francisco J. Alonso
Department of Molecular Biology and Biochemistry, Faculty of Sciences, University of Malaga, 29071 Málaga, Spain
1 shared publicationJ. Michael Bishop
G.W. Hooper Research Foundation, University of California San Francisco, San Francisco, CA 94143-0552, USA
1 shared publication- José Manuel Matés
Canceromics Lab, Departamento de Biología Molecular y Bioquímica, Universidad de Málaga, 29071 Málaga, Spain
1 shared publication Richard M. Higashi
Center for Regulatory and Environmental Analytical Metabolomics (CREAM), Department of Chemistry, University of Louisville, Louisville, KY 40208, USA
1 shared publication
Latest Publications
- 1 February 2012
- Published by Elsevier in Cell Metabolism
- Vol. 15 (2) , 157-170
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
- 1 February 2012
- Published by Elsevier in Cell Metabolism
- Vol. 15 (2) , 157-170
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
- 15 July 2008
- Published by Taylor & Francis in Cell Cycle
- Vol. 7 (14) , 2083-2089
Finding an “Achilles’ heel” of cancer: The role of glucose and glutamine metabolism in the survival of transformed cells
Multiple lines of evidence indicate that the process of tumorigenesis is often associated with altered metabolism of two major nutrients, glucose and glutamine. These two nutrients are engaged in multiple metabolic pathways that can be required for cell viability. The roles of glucose and glutamine in the survival of transformed cells both in vitro and in vivo have been separately evaluated in various cell systems, and glucose as the major cellular energy source has received most of the attention. At the same time, data suggests that the inclusion of glucose and glutamine into specific metabolic pathways and cellular sensitivity to the availability of either of these nutrients depends on the cell origin and the combination and nature of transforming events. Exploiting cell metabolism to develop selective cancer therapeutics requires consideration of these factors and evaluation of the requirement of glucose and glutamine metabolism for survival of different transformed cells. Here we discuss possible molecular mechanisms underlying oncogene-induced sensitivity to deprivation of these nutrients.
- 15 July 2008
- Published by Taylor & Francis in Cell Cycle
- Vol. 7 (14) , 2083-2089
Finding an “Achilles’ heel” of cancer: The role of glucose and glutamine metabolism in the survival of transformed cells
Multiple lines of evidence indicate that the process of tumorigenesis is often associated with altered metabolism of two major nutrients, glucose and glutamine. These two nutrients are engaged in multiple metabolic pathways that can be required for cell viability. The roles of glucose and glutamine in the survival of transformed cells both in vitro and in vivo have been separately evaluated in various cell systems, and glucose as the major cellular energy source has received most of the attention. At the same time, data suggests that the inclusion of glucose and glutamine into specific metabolic pathways and cellular sensitivity to the availability of either of these nutrients depends on the cell origin and the combination and nature of transforming events. Exploiting cell metabolism to develop selective cancer therapeutics requires consideration of these factors and evaluation of the requirement of glucose and glutamine metabolism for survival of different transformed cells. Here we discuss possible molecular mechanisms underlying oncogene-induced sensitivity to deprivation of these nutrients.